Download FREE Report Sample
Download Free sampleCefdinir, also known as Omnicef, is a semi-synthetic, broad-spectrum antibiotic belonging to the third generation of the cephalosporin class. It has been proven to be effective for the treatment of common bacterial infections in the ear, sinus, throat, lungs, and skin.?
Omnicef Market contains market size and forecasts of Omnicef in global, including the following market information:
Global Omnicef Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Omnicef Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Omnicef companies in 2021 (%)
The global Omnicef market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Omnicef include Astellas Pharma, Sandoz (Novartis), TEVA, Aurobindo, ORCHID PHARMA, LUPIN, YONGNING PHARMA, CSPC and GENCOM, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Omnicef manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Omnicef Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Omnicef Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsule
Global Omnicef Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Omnicef Market Segment Percentages, by Application, 2021 (%)
Infections In The Ear
Infections In The Sinus
Infections In The Throat
Infections In The Lungs
Infections In The Skin
Other
Global Omnicef Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Omnicef Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Omnicef revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Omnicef revenues share in global market, 2021 (%)
Key companies Omnicef sales in global market, 2017-2022 (Estimated), (KG)
Key companies Omnicef sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma
Sandoz (Novartis)
TEVA
Aurobindo
ORCHID PHARMA
LUPIN
YONGNING PHARMA
CSPC
GENCOM
QILU ANTIBIOTICS
UNION CHEMPHARMA
HANSOH
LUKANG
Tianjin Huajin Pharmaceutical
Tianjin Central Pharmaceutical
Guangdong Bozhou Pharmaceutical
Jiangsu Yabang Qiangsheng Pharmaceutical
Hainan Rizhongtian Pharmaceutical
Heilongjiang Zhaodong Huafu Pharmaceutical
Tianjin Pharmaceutical Group Jinkang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Zhejiang Jutai Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
